Research Funding

  • Harnessing Data Science for Health Discovery and Innovation in Africa

 

High-Risk Research: NIH Director's Early Independence Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) 4/27/2022 RFA-RM-22-021 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
Letter of Intent:
8/2/2022
Receipt Date:
9/2/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 

High-Risk Research: NIH Director's New Innovator Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional) 4/7/2022 RFA-RM-22-019 Patricia (Trish) Labosky

NewInnovatorAwards@mail.nih.gov

301-594-4863
Receipt date:
8/19/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Pioneer Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
2023 NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) 4/13/2022 RFA-RM-22-018 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
9/9/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Transformative Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) 5/12/2022 RFA-RM-22-020 Ravi Basavappa
Transformative_Awards@mail.nih.gov (link sends e-mail)
(301) 435-7204
9/1/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 

Somatic Cell Genome Editing (SCGE) Program

Title NIH Guide RFA Number NIH Contact Receipt Date
Platform Clinical Trials of Somatic Genome Editing for Multiple Diseases (UG3/UH3, Clinical Trial Required) 4/11/2022 RFA-RM-22-016 P.J. Brooks
pj.brooks@mail.nih.gov
301-443-0513
Letter of Intent:
10/7/2022
Application Receipt Date:
11/10/2022

Harnessing Data Science for Health Discovery and Innovation in Africa

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date

Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Partnership for Innovation Research Projects (U01 Clinical Trial Not Allowed)

5/27/2022 RFA-RM-22-023 Brad Newsome
DS-IU01Mailbox@mail.nih.gov
301-451-1390
Letter of Intent:
8/29/2022
Receipt Dates:
9/28/2022
AIDS: 12/6/2022
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Research Education Program (UE5 Clinical Trial Not Allowed) 5/27/2022 RFA-RM-22-022 Laura Povlich
DS-IAfricaUE5@mail.nih.gov
301 827-2227
Letter of Intent:
8/29/2022
Receipt Dates:
9/28/2022

Past Funding Opportunities

 

 

This page last reviewed on July 21, 2022